All Topics

December 16, 2022 | Controlled Substances, Harm Reduction, Innovative Initiatives, Opioids, Prescription Drugs, Public Health, Recovery, Substance Abuse, Treatments

In October 2022, Wisconsin’s Department of Health Services (DHS), in conjunction with the state’s department of justice (DOJ) and the Office of Governor Tony Ever announced the launch of the Real Talks campaign to help address the rise in substance use in the state. In recent years, much like the rest of the country, Wisconsin has seen a sizable increase in opioid-related deaths. In fact, between 2018 and 2020, the number of opioid-related deaths increased by 46.7 percent. In addition, alcohol misuse continues to be a problem. Data from DHS indicates that adults in the state rank third in the United States for alcohol use. Real Talks Wisconsin is part of a series of DHS programs aimed at preventing and reducing substance use or abuse within the state. Real Talks discusses community prevention programs and encourages harm reduction programs, such as free access to emergency opioid antagonists....

December 7, 2022 | Controlled Substances, Criminal Justice, Fact Sheets, Opioids, Substance Abuse, Treatments

Withdrawal syndrome occurs in individuals who have developed physiological dependence on a substance and who discontinue or reduce their use of it. Individuals who use drugs or alcohol prior to incarceration may experience the onset of withdrawal syndrome while in a correctional setting. This fact sheet discusses the management of withdrawal symptoms of individuals in the corrections system....

December 6, 2022 | Case Law Monitor

Case Law Monitor is the bimonthly case law newsletter of the Legislative Analysis and Public Policy Association (LAPPA). Each issue will highlight unique cases from around the United States in the areas of public health and safety, substance use disorders, and the criminal justice system. ...

November 14, 2022 | News Bites

Each issue of News Bites will highlight unique news articles from around the United States in the areas of public health and safety, substance use disorders, and the criminal justice system. This newsletter will feature stories that you may have missed but are important to the field....

November 1, 2022 | Controlled Substances, Fact Sheets, Fetal and Infant Health, Maternal Health, Opioids, Substance Abuse, Treatments

There are a number of expert recommendations regarding how to identify, work with, and treat pregnant and postpartum individuals with SUD to ensure the best outcomes for both parent and child. There are also legal requirements regarding notification to state child welfare agencies of infants born affected by prenatal substance exposure or experiencing withdrawal and the creation of family care plans (also known as plans of safe care). This fact sheet provides readers with an overview of those recommendations and requirements.intervention....

October 25, 2022 | Controlled Substances, Criminal Justice, Fact Sheets, Harm Reduction, Medication Assisted Treatment (MAT), Opioids, Recovery, Substance Abuse, Treatments

Through the use of medications for addiction treatment (MAT), an individual’s substance use, withdrawal symptoms, and the physiological and psychological cravings can be controlled, enabling the person to begin treatment while in a correctional facility and be released as a person in, or on his or her way to, recovery. Research shows that that the use of MAT for Opioid Use Disorder in correctional settings is a cost-effective and life-saving intervention....

October 5, 2022 | Case Law Monitor

Case Law Monitor is the bimonthly case law newsletter of the Legislative Analysis and Public Policy Association (LAPPA). Each issue will highlight unique cases from around the United States in the areas of public health and safety, substance use disorders, and the criminal justice system. ...

October 5, 2022 | Controlled Substances, Fact Sheets, Opioids

Kratom is an herb that is derived from a leafy Southeast Asian tree, known formally as Mitragyna speciosa. It contains two psychoactive compounds, mitragynine and 7-hydroxymitragynine, which can produce a pharmacological response that is similar to that produced by morphine. Federal regulators and kratom organizations are at odds about the potential dangers (or lack thereof) of kratom and how kratom should be regulated. In addition to federal regulatory battles, some state and local governments have implemented regulatory controls on kratom. ...

September 8, 2022 | News Bites

Each issue of News Bites will highlight unique news articles from around the United States in the areas of public health and safety, substance use disorders, and the criminal justice system. This newsletter will feature stories that you may have missed but are important to the field....